These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25810123)

  • 1. Glucose-Lowering Effect of Sevelamer Hydrochloride in Hemodialysis Patients.
    Ikee R; Hashimoto N
    Ther Apher Dial; 2015 Aug; 19(4):412-3. PubMed ID: 25810123
    [No Abstract]   [Full Text] [Related]  

  • 2. Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients.
    Ohno I; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Okabe H; Ichida K; Hosoya T
    Intern Med; 2009; 48(6):415-20. PubMed ID: 19293539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.
    Ueda S; Nagai K; Yokota N; Hirose D; Mori H; Noma Y; Doi T; Minakuchi J
    J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin A1c in hemodialysis patients: should one size fit all?
    Ix JH
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
    Liu YL; Lin HH; Yu CC; Kuo HL; Yang YF; Chou CY; Lin PW; Liu JH; Liao PY; Huang CC
    Ren Fail; 2006; 28(8):701-7. PubMed ID: 17162430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
    Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
    J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
    Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
    Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
    Prajapati VA; Galani VJ; Shah PR
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):530-8. PubMed ID: 24821148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.
    Jung HS; Kim HI; Kim MJ; Yoon JW; Ahn HY; Cho YM; Oh KH; Joo KW; Lee JG; Kim SY; Park KS
    Diabetes Technol Ther; 2010 Oct; 12(10):801-7. PubMed ID: 20809681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.
    Sun PP; Perianayagam MC; Jaber BL
    J Ren Nutr; 2009 Sep; 19(5):432-8. PubMed ID: 19464926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.